Top compounds associated with response to PRY2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BEC CTRPv2 pan-cancer AAC 0.22 0.002
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.003
mRNA fingolimod CTRPv2 pan-cancer AAC 0.11 0.005
mRNA BRD-K51490254 CTRPv2 pan-cancer AAC 0.11 0.005
mRNA AZD6244 CTRPv2 pan-cancer AAC 0.11 0.005
Download CSV